These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23704424)

  • 1. Visual hallucinations in photographs in Parkinson's disease.
    Vaou O; Saint-Hilaire M; Friedman J
    BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23704424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive identification of delusions and olfactory, tactile, gustatory, and minor hallucinations in Parkinson's disease psychosis.
    Kulick CV; Montgomery KM; Nirenberg MJ
    Parkinsonism Relat Disord; 2018 Sep; 54():40-45. PubMed ID: 29653909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hallucinations in Parkinson's disease--a study of forty three patients.
    Gupta M; Singh G; Khwaja GA; Mehndiratta MM
    J Assoc Physicians India; 2004 Sep; 52():703-6. PubMed ID: 15839446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delusions and visual hallucinations in a patient with Parkinson's disease with dementia showing pronounced Lewy body pathology in the nucleus basalis of Meynert.
    Sakai K; Ikeda T; Ishida C; Komai K; Yamada M
    Neuropathology; 2019 Aug; 39(4):319-323. PubMed ID: 31243794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hallucinations, delusions, and nocturnal events in 152 Parkinson's patients: a regional survey].
    Bailbé M; Karolewicz S; Neau JP; Dumas P; Gil R;
    Rev Neurol (Paris); 2002 Feb; 158(2):203-10. PubMed ID: 11965176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of hallucinations and delusions in Parkinson's disease.
    Holroyd S; Currie L; Wooten GF
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):734-8. PubMed ID: 11385005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical elevation of plasma C-reactive protein and illusions/hallucinations in subjects with Parkinson's disease: case-control study.
    Sawada H; Oeda T; Umemura A; Tomita S; Hayashi R; Kohsaka M; Yamamoto K; Sudoh S; Sugiyama H
    PLoS One; 2014; 9(1):e85886. PubMed ID: 24497930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delusions, illusions and hallucinations in epilepsy: 1. Elementary phenomena.
    Elliott B; Joyce E; Shorvon S
    Epilepsy Res; 2009 Aug; 85(2-3):162-71. PubMed ID: 19423297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining visual illusions in Parkinson's disease: Kinetopsia and object misidentification illusions.
    Nishio Y; Yokoi K; Hirayama K; Ishioka T; Hosokai Y; Gang M; Uchiyama M; Baba T; Suzuki K; Takeda A; Mori E
    Parkinsonism Relat Disord; 2018 Oct; 55():111-116. PubMed ID: 29891431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive correlates of hallucinations and delusions in Parkinson's disease.
    Factor SA; Scullin MK; Sollinger AB; Land JO; Wood-Siverio C; Zanders L; Freeman A; Bliwise DL; McDonald WM; Goldstein FC
    J Neurol Sci; 2014 Dec; 347(1-2):316-21. PubMed ID: 25466695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative.
    Ffytche DH; Pereira JB; Ballard C; Chaudhuri KR; Weintraub D; Aarsland D
    J Neurol Neurosurg Psychiatry; 2017 Apr; 88(4):325-331. PubMed ID: 28315846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hallucinations and sleep disturbances in Parkinson's disease.
    Kulisevsky J; Roldan E
    Neurology; 2004 Oct; 63(8 Suppl 3):S28-30. PubMed ID: 15505140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's disease.
    Zoldan J; Friedberg G; Weizman A; Melamed E
    Adv Neurol; 1996; 69():541-4. PubMed ID: 8615178
    [No Abstract]   [Full Text] [Related]  

  • 14. Donepezil in the treatment of hallucinations and delusions in Parkinson's disease.
    Fabbrini G; Barbanti P; Aurilia C; Pauletti C; Lenzi GL; Meco G
    Neurol Sci; 2002 Apr; 23(1):41-3. PubMed ID: 12111620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early dopaminergic drug-induced hallucinations in parkinsonian patients.
    Goetz CG; Vogel C; Tanner CM; Stebbins GT
    Neurology; 1998 Sep; 51(3):811-4. PubMed ID: 9748031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Othello syndrome in Parkinson's disease: a systematic review and report of a case series.
    De Michele G; Palmieri GR; Pane C; Dello Iacovo CDP; Perillo S; Saccà F; De Michele G; De Rosa A
    Neurol Sci; 2021 Jul; 42(7):2721-2729. PubMed ID: 33978871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deconstructing psychosis and misperception symptoms in Parkinson's disease.
    Nishio Y; Yokoi K; Uchiyama M; Mamiya Y; Watanabe H; Gang M; Baba T; Takeda A; Hirayama K; Mori E
    J Neurol Neurosurg Psychiatry; 2017 Sep; 88(9):722-729. PubMed ID: 28600444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pimavanserin approved for Parkinson's-related hallucinations, delusions.
    Traynor K
    Am J Health Syst Pharm; 2016 Jun; 73(12):853. PubMed ID: 27261226
    [No Abstract]   [Full Text] [Related]  

  • 19. Characteristics, correlates, and assessment of psychosis in Parkinson disease without dementia.
    Barrett MJ; Smolkin ME; Flanigan JL; Shah BB; Harrison MB; Sperling SA
    Parkinsonism Relat Disord; 2017 Oct; 43():56-60. PubMed ID: 28735797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diplopia in Parkinson's disease: visual illusion or oculomotor impairment?
    Visser F; Vlaar AMM; Borm CDJM; Apostolov V; Lee YX; Notting IC; Weinstein HC; Berendse HW
    J Neurol; 2019 Oct; 266(10):2457-2464. PubMed ID: 31214767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.